Showing results (361-370 of 1,831) with videos related to
Sort By:
Pageof 184
ESMO Open|April 25, 2025
Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trialG Schepisi, M Urbini, C Casadei, et al.ESMO Open|April 11, 2025
Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyJ Rodon, M Rothe, P K Mangat, et al.ESMO Open|April 12, 2025
Exposure-response relationship of niraparib in maintenance therapy for recurrent ovarian cancer: ancillary analysis of the French GINECO-NiQoLe studyS Quesada, A Puszkiel, A Jouinot, et al.ESMO Open|April 2, 2025
Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesotheliomaL Möhrmann, M Werner, M Oleś, et al.ESMO Open|April 2, 2025
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world studyC Marchetti, A Fagotti, R Fruscio, et al.ESMO Open|June 7, 2023
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databasesP Martin, Z Tsourti, J Ribeiro, et al.ESMO Open|March 12, 2026
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscapeF Gay, G Buda, M T Petrucci, et al.ESMO Open|March 5, 2026
Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinomaA D Colevas, V Chin, J J Park, et al.ESMO Open|February 26, 2026
Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinomaK Shitara, Y-J Bang, L S Wyrwicz, et al.ESMO Open|June 28, 2023
Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trialJ Rodon Ahnert, D S-W Tan, I Garrido-Laguna, et al.Pageof 184